On-Demand Webinars
-
Smarter CMC Strategies To Accelerate Next-Gen Biologics To The Clinic
10/23/2025
Learn how process design and cross-functional collaboration mitigate risks and accelerate the path from early development to FIH manufacturing through real-world case studies of practical approaches.
-
Your Journey To GMP With Emphasis On Linker Payload Development
10/22/2025
Develop lower-risk conjugation strategies by incorporating the critical insights we highlight in our review of semi-synthetic versus synthetic linker–payloads and their respective advantages and limitations.
-
Enhancing Non-Viral CAR T Manufacturing With Electroporation And Microbubble T Cell Isolation
10/22/2025
Unlock superior non-viral CAR T manufacturing outcomes by combining gentle microbubble T cell isolation with advanced electroporation. See how this approach boosts cell viability and transfection efficiency.
-
Game-Changing CLD Platforms: Strategies, Technologies, Workflows
10/21/2025
Selecting the right cell line platform is complex. Learn how flexible strategies, integrated technologies, and expert workflows enable high productivity, rapid timelines, and a de-risked path to clinical success.
-
In-Line PAT Solutions For cGMP Environments
10/21/2025
Learn how real-time monitoring and PAT platforms can streamline bioprocessing, reduce testing delays, and improve decision-making across upstream and downstream workflows.
-
Development Of An Off-The-Shelf γδ T-Cell Platform
10/20/2025
Learn how γδ T cells are being engineered into scalable, off-the-shelf therapies with enhanced safety and potency, as well as discover strategies to overcome immunological barriers.
-
AI In Action: Driving Operational Excellence In Life Sciences
10/20/2025
Discover how combining domain expertise with advanced AI and data engineering automates compliance, accelerates readiness, and provides real-time insights for confident decision-making.
-
Maximizing Yield And Purity With Praesto™ CH1 Resin
10/17/2025
Explore a new resin designed to simplify antibody purification, improve yield, and enhance contaminant removal during the capture step—ideal for complex therapeutics and GMP workflows.
-
Selective Degradation Of Cancer Target WDR5
10/17/2025
Explore how to enable precise biophysical characterization of PROTACs targeting WDR5 to help overcome challenges with undruggable cancer proteins and complex interactions.
-
How To Keep Your Degrader Pipeline Moving Forward
10/17/2025
Discover a new biophysical method that simplifies PROTAC characterization, improves assay development, and delivers high-quality affinity data even for complex interactions.